Ginsenoside Rg3-induced EGFR/MAPK pathway deactivation inhibits melanoma cell proliferation by decreasing FUT4/LeY expression
Open Access
- 10 February 2015
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 46 (4), 1667-1676
- https://doi.org/10.3892/ijo.2015.2886
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 39 references indexed in Scilit:
- High Expression of Lewis y Antigen and CD44 Is Correlated with Resistance to Chemotherapy in Epithelial Ovarian CancersPLOS ONE, 2013
- Latest Approved Therapies for Metastatic Melanoma: What Comes Next?Journal of Skin Cancer, 2013
- Therapeutic Targeting of Lewisy and Lewisb with a Novel Monoclonal Antibody 692/29PLOS ONE, 2013
- Elevated Levels of Lewis Y and Integrin α5β1 Correlate with Chemotherapeutic Drug Resistance in Epithelial Ovarian CarcinomaInternational Journal of Molecular Sciences, 2012
- Differential fucosyltransferase IV expression in squamous carcinoma cells is regulated by promoter methylationCellular & Molecular Biology Letters, 2012
- Study on the Expression and Clinical Significances of Lewis y Antigen and Integrin αv, β3 in Epithelial Ovarian TumorsInternational Journal of Molecular Sciences, 2011
- Overexpression of fucosyltransferase IV promotes A431 cell proliferation through activating MAPK and PI3K/Akt signaling pathwaysJournal of Cellular Physiology, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- Overexpression of fucosyltransferase IV in A431 cell line increases cell proliferationThe International Journal of Biochemistry & Cell Biology, 2007
- Inhibition of Xenograft Tumor Growth and Down-Regulation of ErbB Receptors by an Antibody Directed against Lewis Y AntigenThe Journal of pharmacology and experimental therapeutics, 2006